Annual Report 2015
Engineering the Medicines
of Tomorrow

Nearly one million people
worldwide were
diagnosed with blood
cancer in 2015.

our research: fighting blood cancer

Antibodies attack
blood cancer cells in
a targeted manner.

our antibody mor208: mode of action

New developments
in the treatment
of blood cancer benefiting
patients.

the mor208 antibody in clinical development

Top